Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM) (THAM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2014 by University of California, San Francisco.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01326260
First received: March 29, 2011
Last updated: October 28, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)